STEPHANIE JONES: Open Payments
NPI 1215770466 · SYLVA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,138 in 59 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $388 · 2025 $1,138
Food & beverage: $1,071Education: $67
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $225 |
| AstraZeneca Pharmaceuticals LP | 7 | $213 |
| Novo Nordisk Inc | 9 | $147 |
| Lilly USA, LLC | 7 | $136 |
| Otsuka America Pharmaceutical, Inc. | 4 | $79 |
| GlaxoSmithKline, LLC. | 4 | $72 |
| JAZZ PHARMACEUTICALS INC. | 1 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| PFIZER INC. | 2 | $38 |
| Axsome Therapeutics, Inc. | 1 | $32 |
Products named: VRAYLAR, FARXIGA, Ozempic, REXULTI, TRELEGY ELLIPTA, MOUNJARO, XYWAV, Kerendia.
Industry payments across NC — which companies pay providers there.
